Why Choose NITYR® (nitisinone) Tablets for Your Patients?

Your patients have a choice

Your patients living with Hereditary Tyrosinemia Type 1 (HT-1) may be unaware of NITYR as an option for nitisinone (NTBC), which has been designed with their interests in mind and may offer greater convenience.

NITYR tablets give you the possibility to adapt to each patient’s changing needs without changing their prescription and helps liberate patients and their caregivers by providing a simpler regimen and support throughout their treatment journey.

Find out more about NITYR

NITYR Fits In with Your Patient’s Life

NITYR tablets are very small and discreet (baby aspirin-sized), which may make it easier for patients to swallow and take on the go.1 From the age of 3, many patients can easily swallow the tablets, after consultation with a healthcare provider.

NITYR Tablets:

  • Can be disintegrated and administered via oral syringe as a suspension
  • Can be crushed and mixed with applesauce
  • Can be swallowed whole
See NITYR’s bioequivalenceEnroll your patients

Most of the top healthcare providers who prescribe nitisinone choose NITYR for their patients with HT-1.

6 of the 7 top children’s hospitals in the US choose NITYR for their patients with HT-1.2II

* Orfadin is a registered trademark, licensed by Swedish Orphan Biovitrum AB (publ) and is marketed by Sobi, Inc.

§ US patient data from January 2023 to February 2024. Institutions ranked by Definitive Healthcare data.

II US patient data from January 2023 to February 2024. Institutions ranked by U.S. News: Best Children’s Hospitals 2023-24.

References

1. Data on file: REF-00041
2. Data on file: REF-00005